Literature DB >> 1188320

ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet rich plasma.

S Holme, H Holmsen.   

Abstract

ADP-induced aggregation was determined at various times of incubation with ADP in unstirred human platelet rich plasma (PRP) to which adenosine deaminase was added. In the early stages of incubation the shape change response was absent, the aggregation response was poor, and not reversible. These three parameters returned slowly towards normal as the incubation proceeded. Pronounced impairment of the aggregation response was present after all added ADP had been degraded in plasma. Log dose-response (rate of aggregation) curves for the platelets incubated with ADP had shifted to higher ADP concentrations and had also a small decrease in maximal height and in the slope compared to those obtained with control platelets. However, the shift in log dose response to higher ADP concentrations was far more striking, so the increase in log dose (R) necessary to obtain the same rate of aggregation as with control PRP was taken as a measure of refractoriness of aggregation towards ADP. R increased with the time of incubation to an optimal value and then decreased. The magnitude of the optimal value and the time at which optimum was reached increased with the concentration of the ADP incubated with the platelets. The variations in R during incubation did not correlate with the breakdown of added ADP. The platelets began to recover their ability to aggregate with ADP while there was still ADP in the system.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1188320     DOI: 10.1111/j.1600-0609.1975.tb01060.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  7 in total

1.  (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.

Authors:  D M Bourdon; S K Mahanty; K A Jacobson; J L Boyer; T K Harden
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization.

Authors:  E M Huang; T C Detwiler
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

Review 3.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

4.  Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

5.  The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.

Authors:  Gilles Kauffenstein; Cristina Ribas Fürstenau; Pedro D'Orléans-Juste; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

6.  Ultrastructure of platelets before and during atrial stimulation. Differences in the coronary sinus and aortic blood in patients with angina pectoris.

Authors:  H Seibold; J Galle; O Haferkamp; M Stauch
Journal:  Klin Wochenschr       Date:  1981-03-02

7.  The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus.

Authors:  Razie Mahmoodian; Morteza Salimian; Mohsen Hamidpour; Ali Akbar Khadem-Maboudi; Ahmad Gharehbaghian
Journal:  BMC Endocr Disord       Date:  2019-06-14       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.